Home      Bondi
Print this page
(back to Lab Members)
Corina Bondi, PhD
 
Biography
 
Corina Bondi grew up in Calarasi, Romania, before moving to New Concord, Ohio in 2000 to attend Muskingum University. There she majored in Neuroscience and Physics. During her undergraduate summers, Corina worked with Cristian Achim, MD, PhD, at the University of Pittsburgh, investigating the distribution of ghrelin, leptin, insulin and their receptors in the human brain. She also designed new viral vectors for gene transfer into ES-derived neuroprogenitor cells.
 
In 2003, Corina began her PhD training in Pharmacology at the University of Texas Health Science Center at San Antonio, where she joined the lab of David Morilak, PhD. During her PhD studies, Corina employed a diverse array of research approaches, including behavioral, neurochemical, pharmacological and functional anatomical, in order to address how changes in the brain noradrenergic modulatory function may play a role in chronic stress-induced cognitive dysfunction in rat medial prefrontal cortex, as well as in mechanisms underlying chronic antidepressant drug effects.
 
Corina joined the Moghaddam Lab as a postdoctoral fellow in 2009. Her current project involves in vivo electrophysiology and pharmacology experiments aiming to characterize the relationship between cortical neural encoding of cognitive behavior and the physiological or abnormal parameters of neurotransmitter function under basal conditions and in response to stress.
 
Publications
 
Bondi, C.O., Matthews, M., Moghaddam, B. Glutamatergic animal models of schizophrenia. Current Pharmaceutical Design, 18(12): 1593-604.
 
Bondi, C.O., Jett, D.J., Morilak, D.A. (2010) Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(6): 913-23.
 
Bondi, C.O., Rodriguez, G., Gould, G.G., Frazer, A., Morilak, D.A. (2008) Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology, 33(2):320-31.
 
Lapiz-Bluhm, M.D., Bondi, C.O., Doyen, J., Rodriguez, G., Bedard-Arana, T., Morilak, D.A. (2008) Behavioral assays to model cognitive and affective components of depressive and anxiety in rats. Journal of Neuroendocrinology, 20(10):1115-37.

Zhao, Z., Baros, A.M., Zhang, H., Lapiz, M.D., Bondi, C.O., Morilak, D.A., O’Donnell, J.M. (2008) Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology, 33(13):3190-200.

Bondi, C.O., Barrera, G., Lapiz, M.D., Bedard, T., Mahan, A., Morilak, D.A. (2007) Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(2):482-95.

Lapiz, M.D., Bondi, C.O., Morilak, D.A. (2007) Chronic treatment with desipramine improves cognitive performance in rats in an attentional set shifting test. Neuropsychopharmacology, 32(5):1000-10.

Lapiz, M.D., Zhao, Z., Bondi, C.O., O’Donnell, J.M., Morilak, D.A. (2007) Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition. International Journal of Neuropsychopharmacology, 10(6):827-33.

Morilak, D.A., Barrera, G., Echevarria, D.J., Garcia, A.S., Hernandez, A., Ma, S., Petre, C.O. (2005) Role of brain norepinephrine in the behavioral response to stress. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(8):1214-24.

Moraru, D., Petre, C.O. (2001) Eureka…The Superlight Speed Physics and Divinity. Calarasi, Romania: AGORA Press (142 pages)

Moraru, D., Petre, C.O. (2000) Historical Notes for the Special Relativity Theory. The Romanian Academy Journal “Academica”, no. 1-2 (121-122).